1
|
Mauna JC, Harris SS, Pino JA, Edwards CM, DeChellis-Marks MR, Bassi CD, Garcia-Olivares J, Amara SG, Guajardo FG, Sotomayor-Zarate R, Terminel M, Castañeda E, Vergara M, Baust T, Thiels E, Torres GE. G protein βγ subunits play a critical role in the actions of amphetamine. Transl Psychiatry 2019; 9:81. [PMID: 30745563 PMCID: PMC6370791 DOI: 10.1038/s41398-019-0387-8] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/2018] [Revised: 10/30/2018] [Accepted: 01/01/2019] [Indexed: 11/18/2022] Open
Abstract
Abnormal levels of dopamine (DA) are thought to contribute to several neurological and psychiatric disorders including drug addiction. Extracellular DA levels are regulated primarily via reuptake by the DA transporter (DAT). Amphetamine, a potent psychostimulant, increases extracellular DA by inducing efflux through DAT. Recently, we discovered that G protein βγ subunits (Gβγ) interact with DAT, and that in vitro activation of Gβγ promotes DAT-mediated efflux. Here, we investigated the role of Gβγ in the actions of amphetamine in DA neurons in culture, ex vivo nucleus accumbens (NAc), and freely moving rats. Activation of Gβγ with the peptide myr-Ser-Ile-Arg-Lys-Ala-Leu-Asn-Ile-Leu-Gly-Tyr-Pro-Asp-Tyr-Asp (mSIRK) in the NAc potentiated amphetamine-induced hyperlocomotion, but not cocaine-induced hyperlocomotion, and systemic or intra-accumbal administration of the Gβγ inhibitor gallein attenuated amphetamine-induced, but not cocaine-induced hyperlocomotion. Infusion into the NAc of a TAT-fused peptide that targets the Gβγ-binding site on DAT (TAT-DATct1) also attenuated amphetamine-induced but not cocaine-induced hyperlocomotion. In DA neurons in culture, inhibition of Gβγ with gallein or blockade of the Gβγ-DAT interaction with the TAT-DATct1 peptide decreased amphetamine-induced DA efflux. Furthermore, activation of Gβγ with mSIRK potentiated and inhibition of Gβγ with gallein reduced amphetamine-induced increases of extracellular DA in the NAc in vitro and in freely moving rats. Finally, systemic or intra-accumbal inhibition of Gβγ with gallein blocked the development of amphetamine-induced, but not cocaine-induced place preference. Collectively, these results suggest that interaction between Gβγ and DAT plays a critical role in the actions of amphetamine and presents a novel target for modulating the actions of amphetamine in vivo.
Collapse
Affiliation(s)
- J. C. Mauna
- 0000 0004 1936 9000grid.21925.3dDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA USA
| | - S. S. Harris
- 0000 0004 1936 8091grid.15276.37Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL USA
| | - J. A. Pino
- 0000 0004 1936 8091grid.15276.37Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL USA
| | - C. M. Edwards
- 0000 0004 1936 9000grid.21925.3dDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA USA
| | - M. R. DeChellis-Marks
- 0000 0004 1936 9000grid.21925.3dDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA USA
| | - C. D. Bassi
- 0000 0004 1936 9000grid.21925.3dDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA USA
| | - J. Garcia-Olivares
- 0000 0001 2297 5165grid.94365.3dLaboratory of Cellular and Molecular Neurobiology, National Institute of Mental Health, NIH, Bethesda, MD USA
| | - S. G. Amara
- 0000 0001 2297 5165grid.94365.3dLaboratory of Cellular and Molecular Neurobiology, National Institute of Mental Health, NIH, Bethesda, MD USA
| | - F. G. Guajardo
- 0000 0004 1936 8091grid.15276.37Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL USA ,0000 0000 8912 4050grid.412185.bLaboratory of Neurochemistry and Neuropharmacology, Center for Neurobiology and Brain Plasticity, Universidad de Valparaíso, Valparaíso, Chile
| | - R. Sotomayor-Zarate
- 0000 0000 8912 4050grid.412185.bLaboratory of Neurochemistry and Neuropharmacology, Center for Neurobiology and Brain Plasticity, Universidad de Valparaíso, Valparaíso, Chile
| | - M. Terminel
- 0000 0001 0668 0420grid.267324.6Department of Psychology, University of Texas at El Paso, El Paso, TX USA
| | - E. Castañeda
- 0000 0001 0668 0420grid.267324.6Department of Psychology, University of Texas at El Paso, El Paso, TX USA
| | - M. Vergara
- 0000 0004 1936 8091grid.15276.37Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL USA
| | - T. Baust
- 0000 0004 1936 9000grid.21925.3dDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA USA
| | - E. Thiels
- 0000 0004 1936 9000grid.21925.3dDepartment of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA USA
| | - G. E. Torres
- 0000 0004 1936 8091grid.15276.37Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL USA ,0000 0004 1936 8091grid.15276.37Center for Addiction Research and Education, University of Florida College of Medicine, Gainesville, FL USA
| |
Collapse
|